FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2924204057> ?p ?o ?g. }

• W2924204057 abstract "Mesenchymal stromal cells (MSCs) are considered potential candidates that hold great promise in the treatment of immune-related diseases. For therapeutic applications, it is necessary to isolate and expand MSCs with procedures complying with good manufacturing practice (GMP). Recent studies reported the use of human serum (HS) instead of fetal bovine serum (FBS) for the expansion of bone marrow-derived MSCs. Nevertheless, there are only limited data on HS as an alternative to FBS for the isolation and expansion of umbilical (UC-MSCs) and placenta-derived MSCs (PL-MSCs). In this study, we evaluate the effect of HS compared to FBS on the proliferative and immunosuppressive capacities of these MSCs.PL-MSCs and UC-MSCs were isolated and cultured in HS- or FBS-supplemented media. The MSC characteristics, including morphology, immunophenotype, and differentiation ability, were verified. The proliferative and immunosuppressive capacities were also examined. In addition, the proliferative-enhancing factors in both sera were explored using proteomic analysis.PL-MSCs and UC-MSCs proliferated faster in HS-supplemented medium than in equivalent levels of FBS-supplemented medium. Adipogenic and osteogenic differentiations occurred at nearly identical levels in HS- and FBS-supplemented media. Interestingly, MSCs cultured in HS-supplemented medium had a similar immunosuppressive effect as MSCs cultured in FBS-supplemented medium. Proteomic analysis revealed that Con-A binding glycoproteins with a molecular weight > 100 kDa in FBS could significantly enhance MSC proliferation. In contrast, the proliferative enhancing factors in HS were found in the Con-A non-binding fraction and WGA binding fraction with a molecular weight > 100 kDa.Taken together, our results suggest applications for the use of HS instead of FBS for the isolation and expansion of PL-MSCs and UC-MSCs for cell therapy in the future. Furthermore, this study identifies factors in HS that are responsible for its proliferative and immunosuppressive effects and might thus lead to the establishment of GMPs for the therapeutic use of MSCs." @default.
• W2924204057 created "2019-04-01" @default.
• W2924204057 creator A5002806501 @default.
• W2924204057 creator A5015726478 @default.
• W2924204057 creator A5021014502 @default.
• W2924204057 creator A5032369855 @default.
• W2924204057 creator A5037733070 @default.
• W2924204057 creator A5084521790 @default.
• W2924204057 date "2019-03-07" @default.
• W2924204057 modified "2023-10-17" @default.
• W2924204057 title "Human serum enhances the proliferative capacity and immunomodulatory property of MSCs derived from human placenta and umbilical cord" @default.
• W2924204057 cites W1596300271 @default.
• W2924204057 cites W1622259963 @default.
• W2924204057 cites W1965013033 @default.
• W2924204057 cites W1965953554 @default.
• W2924204057 cites W1977689261 @default.
• W2924204057 cites W1982408656 @default.
• W2924204057 cites W1984702561 @default.
• W2924204057 cites W1993000555 @default.
• W2924204057 cites W2016011302 @default.
• W2924204057 cites W2019495971 @default.
• W2924204057 cites W2024088021 @default.
• W2924204057 cites W2025371271 @default.
• W2924204057 cites W2039751388 @default.
• W2924204057 cites W2040771492 @default.
• W2924204057 cites W2041971960 @default.
• W2924204057 cites W2044695442 @default.
• W2924204057 cites W2051297632 @default.
• W2924204057 cites W2053976497 @default.
• W2924204057 cites W2069937776 @default.
• W2924204057 cites W2073238549 @default.
• W2924204057 cites W2088964957 @default.
• W2924204057 cites W2091610929 @default.
• W2924204057 cites W2091776667 @default.
• W2924204057 cites W2095666785 @default.
• W2924204057 cites W2095856978 @default.
• W2924204057 cites W2100764718 @default.
• W2924204057 cites W2108424502 @default.
• W2924204057 cites W2109606739 @default.
• W2924204057 cites W2111553051 @default.
• W2924204057 cites W2127722636 @default.
• W2924204057 cites W2128957474 @default.
• W2924204057 cites W2131004666 @default.
• W2924204057 cites W2139800089 @default.
• W2924204057 cites W2155538176 @default.
• W2924204057 cites W2159358845 @default.
• W2924204057 cites W2159999899 @default.
• W2924204057 cites W2165319206 @default.
• W2924204057 cites W2193239567 @default.
• W2924204057 cites W2312444900 @default.
• W2924204057 cites W2412036755 @default.
• W2924204057 cites W2485516716 @default.
• W2924204057 cites W2766025104 @default.
• W2924204057 cites W2766654377 @default.
• W2924204057 cites W2773660430 @default.
• W2924204057 cites W2775091487 @default.
• W2924204057 cites W2778341848 @default.
• W2924204057 cites W2806182937 @default.
• W2924204057 cites W3024505261 @default.
• W2924204057 doi "https://doi.org/10.1186/s13287-019-1175-3" @default.
• W2924204057 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6407186" @default.
• W2924204057 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30845980" @default.
• W2924204057 hasPublicationYear "2019" @default.
• W2924204057 type Work @default.
• W2924204057 sameAs 2924204057 @default.
• W2924204057 citedByCount "25" @default.
• W2924204057 countsByYear W29242040572020 @default.
• W2924204057 countsByYear W29242040572021 @default.
• W2924204057 countsByYear W29242040572022 @default.
• W2924204057 countsByYear W29242040572023 @default.
• W2924204057 crossrefType "journal-article" @default.
• W2924204057 hasAuthorship W2924204057A5002806501 @default.
• W2924204057 hasAuthorship W2924204057A5015726478 @default.
• W2924204057 hasAuthorship W2924204057A5021014502 @default.
• W2924204057 hasAuthorship W2924204057A5032369855 @default.
• W2924204057 hasAuthorship W2924204057A5037733070 @default.
• W2924204057 hasAuthorship W2924204057A5084521790 @default.
• W2924204057 hasBestOaLocation W29242040571 @default.
• W2924204057 hasConcept C1491633281 @default.
• W2924204057 hasConcept C16685009 @default.
• W2924204057 hasConcept C185592680 @default.
• W2924204057 hasConcept C196166836 @default.
• W2924204057 hasConcept C198826908 @default.
• W2924204057 hasConcept C203014093 @default.
• W2924204057 hasConcept C2776955114 @default.
• W2924204057 hasConcept C2779404806 @default.
• W2924204057 hasConcept C2780007613 @default.
• W2924204057 hasConcept C28328180 @default.
• W2924204057 hasConcept C553184892 @default.
• W2924204057 hasConcept C55493867 @default.
• W2924204057 hasConcept C71924100 @default.
• W2924204057 hasConcept C86803240 @default.
• W2924204057 hasConcept C8891405 @default.
• W2924204057 hasConcept C95444343 @default.
• W2924204057 hasConceptScore W2924204057C1491633281 @default.
• W2924204057 hasConceptScore W2924204057C16685009 @default.
• W2924204057 hasConceptScore W2924204057C185592680 @default.
• W2924204057 hasConceptScore W2924204057C196166836 @default.
• W2924204057 hasConceptScore W2924204057C198826908 @default.
• W2924204057 hasConceptScore W2924204057C203014093 @default.

• next